Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Diabetic complication
ADR ID BADD_A05783
ADR Hierarchy
05      Endocrine disorders
05.07      Diabetic complications
05.07.03      Diabetic complications NEC
05.07.03.002      Diabetic complication
14      Metabolism and nutrition disorders
14.07      Diabetic complications
14.07.03      Diabetic complications NEC
14.07.03.002      Diabetic complication
Description Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE. [MeSH]
MedDRA Code 10061104
MeSH ID D048909
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Diabetes with other specified manifestations | Diabetes with unspecified complication | Diabetes with unspecified complications | Diabetic complication NOS | Type I diabetes mellitus with other specified manifestations | Type I diabetes mellitus with unspecified complication | Type II diabetes mellitus with other specified manifestations | Type II diabetes mellitus with unspecified complication | Diabetic complication | Diabetic triopathy | Diabetes Complications | Diabetes Complication | Diabetes-Related Complications | Diabetes Related Complications | Diabetes-Related Complication | Diabetic Complications | Diabetic Complication | Complications of Diabetes Mellitus | Diabetes Mellitus Complication | Diabetes Mellitus Complications
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00156Apremilast0.000651%
BADD_D00285Bosentan0.000241%
BADD_D00344Canagliflozin--
BADD_D00511Clozapine0.004280%
BADD_D00551Cyclosporine0.000166%
BADD_D00858Everolimus0.000229%
BADD_D01253Lenalidomide0.000844%
BADD_D01300Lisinopril--
BADD_D01567Nilotinib0.000358%
BADD_D01676Paricalcitol0.001962%
BADD_D01798Pomalidomide0.000241%
BADD_D01835Pregabalin0.000104%
BADD_D02029Sitagliptin0.000212%
BADD_D02053Sofosbuvir0.000282%
BADD_D02331Valsartan0.000053%
BADD_D02434Cinacalcet0.000391%
BADD_D02436Atorvastatin0.000011%
The 1th Page    1    Total 1 Pages